Navigation Links
Atonomics Achieves Significant Milestone Related to Performance Data for Troponin I Assay Triggering Scheduled Payments From Beckman Coulter
Date:11/26/2012

COPENHAGEN, Denmark, November 26, 2012 /PRNewswire/ --

Atonomics A/S announced today that it has achieved an important milestone related to a defined set of performance criteria for a Troponin I assay on the new Atolyzer® system.

     (Logo: http://photos.prnewswire.com/prnh/20121126/578019)

Since entering an equity investment agreement with Beckman Coulter in May of last year to advance the Atolyzer® within cardiac testing, the company has worked diligently to deliver relevant Troponin I performance data.

"We are pleased to achieve this milestone," said Thomas Warthoe, Atonomics' CEO. "Troponin I is one of the most difficult assays to transfer to a near-patient system and still deliver data that are comparable to what the physicians get from the central laboratory; we believe the Atolyzer® has the potential to allow physicians in the future to continue to safely implement data from a near patient system."

"We expect that this recent and significant achievement will generate appropriate interest from Industry in order to reach the full potential of the Atolyzer® platform," said Ashok Dhanrajgir, Chairman of Atonomics board of directors and senior partner with Inventages Venture Capital

Atonomics' majority shareholders are Inventages Venture Capital, Sunstone Capital, NeuroSearch A/S,  and Beckman Coulter.

About Atonomics

Atonomics is an emerging technology company based in Copenhagen, Denmark, that designs and manufactures the innovative Atolyzer® system for near-patient testing in hospitals, clinics, physician offices  and patient monitoring. Atonomics is pursuing a strategy to partner with leading players in the industry to bring a new dimension of quality to the point-of-care market. The Atolyzer® system is a platform for immuno-diagnostic and molecular diagnostic testing. The Atolyzer® is designed for simplicity and ease of use while preserving performance and safety. The stand-alone device is operated with a single touch by any health worker and can be positioned in any location throughout the hospital, clinic or office where large systems cannot operate, representing true near-patient testing.

Contacts:

Atonomics
Thomas Warthoe, CEO
Phone: +45-70271330
Email: tw@atonomics.com 
Web: http://www.atonomics.com


'/>"/>
SOURCE Atonomics A/S
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Greenville Hospital System Achieves Dramatic Improvement in Hand Hygiene Compliance Rates Using New Technology from DebMed®
2. Acuo Technologies Grows European Business and Achieves Successful Connectathon Results in Bern, Switzerland
3. CMC Biologics Achieves Successful Pre-Approval European GMP Inspection by MHRA for Commercial Manufacturing
4. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
5. South Carolinas Stop-Sale System Achieves Significant Results In Battle Against Meth
6. Tennessee Stop-Sale System Achieves Significant Results In Battle Against Meth
7. Indianas Stop-Sale System Achieves Significant Results In Battle Against Meth
8. Alabamas Stop-Sale System Achieves Significant Results In Battle Against Meth
9. Missouri Stop-Sale System Achieves Significant Results In Battle Against Meth
10. Kansas Stop-Sale System Achieves Significant Results In Battle Against Meth
11. Illinois Stop-Sale System Achieves Significant Results In Battle Against Meth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
(Date:6/23/2016)... -- The National Pharmaceutical Council (NPC) today announced that ... organization as its newest member.  ... and chief scientific officer, Mallinckrodt Pharmaceuticals, will serve ... of Directors. ... in support of our efforts to conduct research ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
Breaking Medicine News(10 mins):